Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs
GeekWire
DECEMBER 27, 2022
He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. Everyone is budgeting 50% longer to raise their rounds,” said Canestaro. In Washington, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology all shed employees in 2022.
Let's personalize your content